Some hormonal contraceptives may raise diabetes risk

02/13/2013 | Toronto Sun · NewKerala.com (India)

Long-acting reversible contraceptives were associated with an increased risk of type 2 diabetes in obese women, according to a study in the journal Contraception. Data on three types of birth-control methods showed women who had progestin-releasing LARC devices implanted under the skin had a 10% increase in fasting blood glucose levels, compared with a 5% increase in those who used a progestin-releasing IUD and a 2% decrease in those who opted for non-hormonal contraceptives.

View Full Article in:

Toronto Sun · NewKerala.com (India)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC